| 000 | 01693 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517024659.0 | ||
| 264 | 0 | _c20160329 | |
| 008 | 201603s 0 0 eng d | ||
| 022 | _a1465-993X | ||
| 024 | 7 |
_a10.1186/s12931-015-0167-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBrill, Simon E | |
| 245 | 0 | 0 |
_aLung function, symptoms and inflammation during exacerbations of non-cystic fibrosis bronchiectasis: a prospective observational cohort study. _h[electronic resource] |
| 260 |
_bRespiratory research _cFeb 2015 |
||
| 300 |
_a16 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Observational Study | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 |
_aBronchiectasis _xblood |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHealth Status |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInflammation Mediators _xblood |
| 650 | 0 | 4 |
_aLung _ximmunology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPeak Expiratory Flow Rate |
| 650 | 0 | 4 |
_aPneumonia _xblood |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRecovery of Function |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aSpirometry |
| 650 | 0 | 4 | _aSurveys and Questionnaires |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aPatel, Anant R C | |
| 700 | 1 | _aSingh, Richa | |
| 700 | 1 | _aMackay, Alexander J | |
| 700 | 1 | _aBrown, Jeremy S | |
| 700 | 1 | _aHurst, John R | |
| 773 | 0 |
_tRespiratory research _gvol. 16 _gp. 16 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s12931-015-0167-9 _zAvailable from publisher's website |
| 999 |
_c24781357 _d24781357 |
||